Nori Ikemoto
Senior Director Porton Pharma
Seminars
Wednesday 29th July 2026
One-Stop Service to ADCs and Payload-Linkers with a Strong US Presencex
2:45 pm
- Site integration to promote rapid development and delivery of ADCs and other bioconjugates with compressed timelines
- Track record in new modalities such as bispecific mAbs and dual payload ADCs
- New Jersey site (J-Star Research) serves as the center of synthetic innovation in HPAPI research
